Czech scientists test psilocybin therapy for depression in multiple sclerosis patients as part of the international PsyPal study.

A single injection of N,N-dimethyltryptamine, the psychedelic compound found in ayahuasca, reversed depression-like symptoms in chronically stressed mice, according to a peer-reviewed study published ...

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

New research suggests that a single dose of the psychedelic compound DMT can reverse symptoms of depression, including loss ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...

A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses ...

A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...

Aerobic exercise, such as running, swimming, and dancing, may be most effective for relieving the symptoms of depression and anxiety, finds an overarching (umbrella) review and data synthesis of the ...